
Ashland Narrows FY2026 Outlook Amid Specialty Chemicals Cyclicality
Ashland narrows FY2026 outlook amid specialty chemicals cyclicality, projecting $386 million revenue (5% YoY decline, 3% adjusted for Avoca divestiture) and $0.75 EPS, with $11 million impacts from Calvert City outage and weather. Focus on efficiency, innovation, and sustainability mitigates volatility in this cyclical market.





